FDA allows emergency use of blood purification technology used in cardiac surgery, critical care for COVID-19

CytoSorbents Corp. announced that its blood purification technology for the treatment of deadly inflammation and cytokine storm has been granted Emergency Use Authorization by the FDA for patients with COVID-19. The technology (CytoSorb), typically used to treat patients who are critically ill or undergoing cardiac surgery, is currently approved […]

Click here to view original web page at www.healio.com